Kendal K. Whitlock leads Healthcare Provider (HCP) network growth, change management, and education for digital (remote/at-home) clinical trials at Boehringer Ingelheim (BI). In this role, she developed the global HCP engagement strategy, and liaises with all other clinical trial enabling functions to establish a customized investigator network. Kendal leverages key insights for end-user learning and change, needed to enable digital capabilities in the clinical research ecosystem.
Kendal holds an MPH from Columbia University, and is currently working toward her doctorate. She earned a BA with honors from Spelman College; completed a post-baccalaureate program at Rutgers, and an intensive summer program at Yale School of Medicine. She values patient empowerment and health equity, and she is ecstatic about the ethical applications of digital health technologies to solve complex healthcare challenges. Kendal was recently selected through a competitive process to Co-Lead the Decentralized Trials Research Alliance (DTRA) 3C Decentralized Research Curriculum, and additionally, appointed to Chair of the Product Development and Clinical Research Sub-committee for the Med Tech Color Collaborative Community.
Kendal has held multiple roles in her tenure with BI. She launched BI’s first web-based Continuing Medical Education (CME) tutorial and established the quality. She was the first to manage BI’s collaboration with the second largest integrated delivery network in the U.S. For a global leadership development program, she created an infectious disease curriculum and taught a 2-day train-the-trainer program in Tamil Nadu, India. She has also served as faculty for a course in Pharma & Biopharmaceutical Entrepreneurship at the Albany College of Pharmacy.
Kendal has been a long-standing champion of the need to improve diversity in clinical trials. With a global team, Kendal contributed to the development of a diabetes education video series customized for South Asian Indian population, which was later awarded gold in the multi-cultural category. She is the US Lead of the Ashoka program to support social entrepreneurs globally. In 2018, Kendal received a President’s Award for the company’s first innovation competition and co-led the development of an Alexa smart speaker skill for CVD risk reduction. Most recently, Kendal, with a collaborative working group, won a pitch competition focused on access to clinical trials at the 2021 Global Patient Partnership Summit.